Remaining Qs here .. 1) How will they shape the
Post# of 154832
(Total Views: 242)
Posted On: 02/28/2019 4:31:18 PM
Remaining Qs here ..
1) How will they shape the Pivotal Monotherapy trial?
In some older CC NP stated that he doesn't necessarily believe he can
use our CD03 trial for pivotal. When being asked, he mumbled something about
skewed or clean data etc. OK.
Maybe FDA allows a separation of 700mg for pivotal mono or not,
maybe FDA allows reusing new 700mg patient data?
As long we have financing in the bag, this should not harm us.
2) Offerings ..
Anything above $10M should be great I think, enabling us to go through BLA
depending on the CMO Partnership deal.
XXXX
What we seem to have
A) Seeking one Cancer MOA Approval for all types
HIV Combo Phase 3
C) 700mg safety data 'soon' within months
XXXX
The trading game is funny, yes, still some cheap shares sold at 50c.
Dividends and/or registration statement related.
So far it seems they all behave to a secret code: Do not sell below 50c.
Shorts used this knowledge a little bit and might be the ones covering as well.
So we have a balance for now.
Monotherapy poster/news, TNBC progress and partnership deal next
1) How will they shape the Pivotal Monotherapy trial?
In some older CC NP stated that he doesn't necessarily believe he can
use our CD03 trial for pivotal. When being asked, he mumbled something about
skewed or clean data etc. OK.
Maybe FDA allows a separation of 700mg for pivotal mono or not,
maybe FDA allows reusing new 700mg patient data?
As long we have financing in the bag, this should not harm us.
2) Offerings ..
Anything above $10M should be great I think, enabling us to go through BLA
depending on the CMO Partnership deal.
XXXX
What we seem to have
A) Seeking one Cancer MOA Approval for all types
HIV Combo Phase 3 C) 700mg safety data 'soon' within months
XXXX
The trading game is funny, yes, still some cheap shares sold at 50c.
Dividends and/or registration statement related.
So far it seems they all behave to a secret code: Do not sell below 50c.
Shorts used this knowledge a little bit and might be the ones covering as well.
So we have a balance for now.
Monotherapy poster/news, TNBC progress and partnership deal next
(0)
(0)